Unitree, the Hangzhou‑based company that has become synonymous with China’s rapid advances in humanoid robotics, is slated to debut on the Shanghai Stock Exchange’s STAR market on Wednesday. The initial public offering has already attracted 6.1 billion yuan (about $905 million) and was oversubscribed more than 8,000 times, a record for the tech‑focused market that China likens to the Nasdaq.
New robot debut and market significance
On Monday the firm unveiled a new humanoid model called “Superman,” which it claims can jump two metres high and run at 12.66 metres per second. The robot follows a series of high‑profile public displays, including a dancing performance at China’s Lunar New Year gala that captured worldwide attention.
Unitree’s founder, Wang Xingxing, was seated in the front row at President Xi Jinping’s rare symposium with top technology firms last year, underscoring the company’s strategic importance to Beijing’s push for leadership in advanced manufacturing and artificial intelligence.
Economic backdrop and policy support
China’s slowing growth and shrinking labor force have prompted the government to pour billions into robotics, describing humanoid machines as “the new high ground of technological competition” in a 2023 policy document. The IPO is viewed as a milestone that could set a benchmark for other Chinese robotics firms seeking capital.
While Unitree will be the first humanoid robot maker listed on a mainland exchange, other Chinese firms such as UBTECH and Dobot already trade in Hong Kong, and Agibot is pursuing a similar listing in Shanghai.
Financial performance and future plans
According to its prospectus, Unitree generated nearly 1.7 billion yuan ($252 million) in revenue in 2025, a ten‑fold increase from two years earlier, and posted a net profit of 278 million yuan ($41 million). About 42 % of its revenue comes from quadruped “robot dogs,” with the remainder driven by sales of humanoid units primarily to research and educational institutions.
The company plans to use IPO proceeds for research and development of embodied AI models, robot hardware, and factory expansion. Analysts note that while Unitree’s hardware and motion‑control capabilities are strong, it must deepen its AI software investments to compete globally.
Geopolitical challenges
Unitree faces headwinds from U.S. restrictions. In June the firm was added to a U.S. blacklist of Chinese companies linked to the military, barring Pentagon contracts. Earlier this year Washington announced a ban on new imports of humanoid and quadruped robots from foreign manufacturers, citing national‑security concerns. Although existing models approved for U.S. sale are exempt, the measures could limit future overseas growth, especially as over 40 % of Unitree’s revenue currently comes from outside China.
Unitree’s prospectus acknowledges the risk, warning that continued U.S. restrictions could curb overseas sales and affect performance.
Industry outlook
Experts say the broader Chinese robotics market already dominates global humanoid sales, outpacing U.S. competitors such as Tesla, Figure AI, and Boston Dynamics. However, full‑scale industrial deployment of bipedal robots remains several years away, with most current applications limited to research labs and limited factory pilots.
Unitree’s partnership with Nvidia, announced in June, aims to strengthen its embodied AI capabilities, addressing a key weakness identified by analysts.
As the STAR market debut approaches, the listing will be watched closely by investors and policymakers alike, offering a barometer for China’s ambition to lead the next wave of advanced manufacturing and AI‑driven automation.
Original reporting: KEYT (Ventura/Santa Barbara) — read the source article.
